---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-26-003620"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2026-03-20T23:59:59+00:00"
generated_at: "2026-05-15T09:29:53.838812+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro receives Nasdaq deficiency notice for stockholders' equity below $2.5M minimum

## Summary
- Stockholders' equity reported at ~$2.2M as of Jan 31, 2026, below Nasdaq's $2.5M minimum requirement for continued listing.
- Company has until May 4, 2026 to submit a plan to regain compliance; if accepted, Nasdaq may grant up to 180 days (to Sept 16, 2026).
- Common stock continues trading on Nasdaq under symbol 'ALZN' with no immediate effect on listing.
- Company is evaluating actions to regain compliance; no assurance plan will be accepted or compliance achieved.

## SEC filing metadata
- accession: 0001214659-26-003620
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2026-03-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465926003620/0001214659-26-003620-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465926003620/g3202628k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-26-003620
- JSON: https://secwatch.observer/filing/0001214659-26-003620.json
- Plain text: https://secwatch.observer/filing/0001214659-26-003620.txt

## Source-grounded claims
- claim_id: cc954f391defbd2d8cea46503a5d04f4c90e7329
  claim: Alzamend Neuro, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  evidence_excerpt: March 20, 2026, Alzamend Neuro, Inc., a Delaware corporation (the “ Company ”) received a letter (the “ Letter ”) from the Listing Qualifications staff (the “ Staff ”) of the Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company’s stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2026 (the “ Form 10-Q ”), did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Market, which requires that a listed company’s stockholders’ equity be at least $2.5 million. As reported on it
  evidence_url: https://www.sec.gov/Archives/edgar/data/1677077/000121465926003620/0001214659-26-003620-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.